About Small Bone Innovations
Small Bone Innovations (SBi) is a orthopedics company focused on technologies and treatments for the small bones & joints. SBi was the first company to focus purely on small bones & joints arthroplasty. It offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in the small bones & joints. SBi has facilities in Morrisville, Pennsylvania, Peronnas, France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia and has sold and distributed its products in 41 countries.
Missing: Small Bone Innovations's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Small Bone Innovations's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Small Bone Innovations
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Small Bone Innovations is included in 1 Expert Collection, including Diabetes.
Small Bone Innovations Patents
Small Bone Innovations has filed 1 patent.
Lower limb anatomy, Bone fractures, Woodworking, Foot, Bones of the foot
Lower limb anatomy, Bone fractures, Woodworking, Foot, Bones of the foot
Latest Small Bone Innovations News
Aug 27, 2020
The report titled SMALL BONE FIXATION SYSTEMS Market: Size, Trends and Forecasts (2020-2025)”, delivers an in-depth analysis of the SMALL BONE FIXATION SYSTEMS market by value, by production capacity, by companies, by applications, by segments, by region, etc. The report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the SMALL BONE FIXATION SYSTEMS industry. Growth of the overall SMALL BONE FIXATION SYSTEMS market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. Get Exclusive Sample copy on SMALL BONE FIXATION SYSTEMS Market is available at https://inforgrowth.com/sample-request/6249641/small-bone-fixation-systems-market Impact of COVID-19: SMALL BONE FIXATION SYSTEMS Market report analyses the impact of Coronavirus (COVID-19) on the SMALL BONE FIXATION SYSTEMS industry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the SMALL BONE FIXATION SYSTEMS market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; emergency declared in many countries; massive slowing of the supply chain; stock market unpredictability; falling business assurance, growing panic among the population, and uncertainty about future. COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets. If you are investor/shareholder in the SMALL BONE FIXATION SYSTEMS Market, the provided study will help you to understand the growth model of SMALL BONE FIXATION SYSTEMS Industry after impact of COVID-19. Request for sample report (including ToC, Tables and Figures with detailed information) @ https://inforgrowth.com/CovidImpact-Request/6249641/small-bone-fixation-systems-market The research report segments the market from a relevancy perspective into the below segments and sub-segments with the quantitative analysis done from 2017 to 2025 considering 2019 as the base year for the research. Compounded Annual Growth Rate (CAGR) for each respective segment and sub-segment is calculated for the forecast period from 2019 to 2025 to provide a reference for growth potential. SMALL BONE FIXATION SYSTEMS market segmented on the basis of Product Type: External Fixation Systems Reasons to Purchase SMALL BONE FIXATION SYSTEMS Market Research Report Develop a competitive strategy based on the competitive landscape Build business strategy by identifying the high growth and attractive SMALL BONE FIXATION SYSTEMS market categories Identify potential business partners, acquisition targets and business buyers Design capital investment strategies based on forecasted high potential segments Prepare management and strategic presentations using the SMALL BONE FIXATION SYSTEMS market data Plan for a new product launch and inventory in advance FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT: Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA Contact Name: Rohan S.
Small Bone Innovations Frequently Asked Questions (FAQ)
When was Small Bone Innovations founded?
Small Bone Innovations was founded in 2004.
Where is Small Bone Innovations's headquarters?
Small Bone Innovations's headquarters is located at 1380 S. Pennsylvania Avenue, Morrisville.
What is Small Bone Innovations's latest funding round?
Small Bone Innovations's latest funding round is Acquired.
How much did Small Bone Innovations raise?
Small Bone Innovations raised a total of $286.2M.
Who are the investors of Small Bone Innovations?
Investors of Small Bone Innovations include Stryker, New Health Capital Partners, NGN Capital, Viscogliosi Brothers, Khazanah Nasional Berhad and 15 more.
Who are Small Bone Innovations's competitors?
Competitors of Small Bone Innovations include Cutera, Paragon Medical, Doctors Research Group, nContact Surgical, Tandem Diabetes Care and 13 more.
Compare Small Bone Innovations to Competitors
Doctors Research Group focuses on producing and marketing medical products. Currently, they are focusing on the development of a new type of bone cement or bone glue called Kryptonite.
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
Satiety, Inc. is a medical device company focused on the development of less invasive devices for the treatment of obesity. Obesity is a global health problem, affecting 70 million people in the U.S. and 300 million worldwide, and growth of which is causing increases in obesity-related diseases such as diabetes, high blood pressure and cardiovascular disease. Obesity surgery has been shown to be the only long-term effective means of weight loss for morbidly obese patients. Satiety's first product, the TOGA System, enables physicians to perform a procedure similar to traditional restrictive obesity surgeries, but without surgical incisions. In this procedure, the TOGA System devices are inserted transorally (through the mouth) and are used to reduce the capacity of the stomach to give patients a feeling of fullness after a small meal. The procedure is intended to be safer and easier for patients to tolerate than conventional obesity surgery. Safety and effectiveness of the TOGA System are currently being evaluated in a multi-center U.S. Study and the system is not available for sale in the United States.
Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.
Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. Endologix is currently marketing its Powerlink Delivery System a, one-piece endoluminal stent graft (ELG) used in treating AAA that has significant advantages when compared with marketed stent alternatives. Powerlink has been commercially available in Europe since 1999. FDA approval for the Powerlink AAA stent graft was received on October 29, 2004. The Powerlink superior design is covered by 17 U.S. patents with 361 allowed claims; the technology is designed to overcome shortcomings of first-generation ELGs. The device is for sale in the United States and selected international markets. Endologix is a publicly-held company trading on NASDAQ: ELGX. The company's corporate office is located in Irvine, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.